Search

Search Constraints

You searched for: Author/Creator Roth, Bruce J

Search Results

1. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. Issue 7 (July 2016)